TriNetX, the global health research network
that revolutionizes clinical research and enables discoveries through the
generation of real-world evidence (RWE), has expanded into South Korea in
alliance with EvidNet, who will add healthcare data from 36M patient records
from 27 hospitals to the TriNetX network.
South Korea ranks sixth globally for
randomized clinical trials (RCTs) and the continued government investment in
infrastructure, global standards, and regulations makes the country
increasingly attractive for pharma interested in clinical research.
"We are excited to have EvidNet join
the TriNetX network," said Maulik Mehta, Senior Vice President of
Corporate Development at TriNetX. "EvidNet's significant presence across
South Korea provides our pharma and CRO partners with immediate access to an
enriched network of healthcare data and patient access and builds on our
growing presence within the Asia-Pacific region."
Collaboration with EvidNet will immediately
offer a new geography for research to current TriNetX customers and potentially
open doors to new local Korean pharma companies. EvidNet provides a
comprehensive healthcare data set currently focused on data derived from EMR
and national claims data standardized into a single common data model and will be
progressively integrating other data generated within the healthcare system
including genomic, radiology and patient-generated health data.
"We are thrilled to be collaborating
with TriNetX," said Brian Jo, MD, Chief Executive Officer of EvidNet.
"They are working with top pharma and CROs and have a proven track record
for accelerating trial placement. We look forward to having our hospitals join
their network in order to bring more trial opportunities to our sites and more
effective therapies to patients."
TriNetX has partnered with healthcare
organizations (HCO) spanning 24 countries and thousands of sites, and with data
providers covering 99% of US health plans to deploy a linked and continually
updated global health research network representing over 300 million patients.
TriNetX has been used to analyze over 20,000 protocols and has presented over
5,800 clinical trial opportunities to its HCO members.
About TriNetX
TriNetX is the global health research
network that revolutionizes clinical research and enables discoveries through
the generation of real-world evidence. TriNetX combines real time access to
longitudinal clinical data with state-of-the-art analytics to answer complex
research questions at the speed of thought. The TriNetX platform is HIPAA and
GDPR compliant. For more information, visit TriNetX at www.trinetx.com or
follow @TriNetX on Twitter.
About EvidNet
EvidNet is the first and only healthcare
data network in Asia, offering a comprehensive healthcare data set standardized
into a single common data model. It was founded to overcome the issues of
sharing medical data for innovative clinical big data research and improve the
quality of medical treatment. EvidNet is revolutionizing the way of healthcare
data innovation through generation of evidence from a fully integrated data
network, ultimately pioneering new paradigms in precision medicine and
efficient healthcare systems. For more information, visit EvidNet at www.evidnet.com.
